🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Hong Kong needs new funding model to draw investment from global drug makers: AstraZeneca

Global - Asia Archived • October 1, 2026 •
Hong Kong needs new funding model to draw investment from global drug makers: AstraZeneca
Hong Kong can attract more global biotech investments if the city builds up a new healthcare financial model, according to AstraZeneca, a Cambridge-based multinational pharmaceutical giant.
While global drug makers have been doubling down on investments in mainland China in recent years, AstraZeneca brought over 60 clinical trials to the city and invested over HK$200 million (US$25.5 million) over the past three years.
Hong Kong was still a key research and development hub for the firm, David...
Source: South China Morning Post | https://www.scmp.com/rss/91/feed - Read Original
"Retirement Health Care"
"House Plans for Structures New and Old"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Adventure is where you chose to go."